TABLE 1.

Baseline Characteristics of Patients With Light Chain Amyloidosis (N = 32)

Age, yrs	62 ± 7
Male	16 (50)
History of prior chemotherapy	14 (44)
Laboratory
Serum creatinine, mg/dl	1.15 ± 0.31
N-terminal pro-BNP, pg/ml	3631 (1,136–7,504)
Serum troponin, ng/ml	0.02 (0–0.1)
Serum free kappa, mg/dl	19.4 (12.2–37.3)
Serum free lambda, mg/dl	64.1 (14.2–172)
Kappa/lambda ratio, unitless	0.21 (0.10–1.27)
AL subtype: lambda AL	25 (78)
Echocardiography—chamber quantification
Left ventricular end-diastolic volume index, ml/m2	41 ± 13
Left ventricular end-systolic volume index, ml/m2	19 ± 9
Left ventricular ejection fraction, %	55 ± 10
Basal septal wall thickness, mm	16.0 ±2.7
Basal inferolateral wall thickness, mm	16.3 ± 2.9
Left ventricular mass index, g/m2	140 ± 39
Left atrial volume index, ml/m2	35 ± 12
Echocardiography—Doppler parameters
E/A velocity ratio, unitless	2.2 ± 1.0
Deceleration time, ms	170 ± 51
E/E′ lateral, unitless	19.9 ± 11.9
E/E′ medial, unitless	22.8 ±10.4
Tricuspid regurgitant peak velocity, m/s	2.50 ± 0.47

Values are mean ± SD, n (%), or median (interquartile range).